This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Radiofrequency ablation (RFA) is an important therapeutic modality for atrialfibrillation (AF), widely utilized in clinical practice due to its safety and significant efficacy. This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardial infarction.
tim.hodson Mon, 11/18/2024 - 10:55 Nov. Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrialfibrillation,” said Christian T. incidence rate for rivaroxaban to a 3.5% vs. 7.7%). [2]
Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Food and Drug Administration approval of the FARAPULSE PFA System in the first quarter of 2024. The company now anticipates U.S. Caution: Investigational Device. Circulation.
milla1cf Mon, 01/29/2024 - 11:00 January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio.
In patients with device-detected atrialfibrillation and a prior stroke, oral anticoagulation increases bleeding without a clear reduction in stroke. This finding was presented by Prof. May 16–19.
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept. On Thursday, Sept.
tim.hodson Tue, 11/19/2024 - 15:57 Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrialfibrillation (AFib) who are at an increased risk of stroke. 16-18, 2024). vs. 90.9%). vs. 83.3%).
Stroke recovery is a challenging process that extends for months after hospital discharge. Navigating Post-Stroke Recovery at Home: One Patient's Experience A ”mildly impaired” stroke patient with atrialfibrillation who was discharged reported, “I knew my local pharmacist, and they knew my prescriptions.
Getty Images milla1cf Tue, 02/27/2024 - 17:24 February 27, 2024 — Biosense Webster, Inc. , Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrialfibrillation (NVAF) treatment.
Stroke, Volume 55, Issue 1 , Page 214-225, January 1, 2024. Nonvalvular atrialfibrillation is a common rhythm disorder of middle-aged to older adults that can cause ischemic strokes and systemic embolism.
Mass screening for atrialfibrillation using ECG together with heart failure biomarker does not prevent ischemic stroke or systemic embolism (blood clot) in older adults aged 75–76 years over 5 years follow-up, according to late breaking research presented in a Hot Line Session at this year's ESC Congress 2024 in London, UK (30 Aug–2 Sept).
Affecting 60 million people worldwide 1 , the prevalence of atrialfibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic risk factors 2. In addition, the Centers for Disease Control and Prevention (CDC) estimates that more than 12 million Americans will have AFib by 2030 3.
Stroke, Volume 56, Issue Suppl_1 , Page AWP87-AWP87, February 1, 2025. Introduction:Continuous electrocardiographic monitoring using an implantable loop recorder (ILR) can facilitate the detection of asymptomatic atrialfibrillation episodes. The median time from implantation to the first detected atrialfibrillation was 115.7
milla1cf Fri, 02/02/2024 - 17:02 February 2, 2024 — Biosense Webster, Inc. , Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Int J Stroke. Int J Stroke.
ISC 2024 Late-breaking Science Finding from ZODIAC Study: Position of Head Before Surgery May Improve Stroke Patient’s Neurological Function 3. ISC 2024 News: Late-Breaking Science Findings from EMBOLISE Clinical Trial Reveals Blocking Artery Supplying the Brain Covering After Subdural Hematoma Reduced Repeat Surgery 4.
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. This includes a doubling of stroke rates.
Results will be presented at the American Heart Association/American Stroke Association ( AHA / ASA ) International Stroke Conference ( ISC ) 2024 in Phoenix. This is due to more frequent AF detection with greater and earlier opportunities to initiate anticoagulation to prevent future AF-related secondary strokes,” said Lee H.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP87-ATMP87, February 1, 2024. Background and purpose:Because the biochemical composition of thrombus changes after formation over time, thrombus maturation in the left atrium may affect clot compositions in ischemic stroke with atrialfibrillation (AF).
Stroke, Volume 55, Issue Suppl_1 , Page AWP12-AWP12, February 1, 2024. Introduction:Uncertainty regarding the timing of anticoagulant initiation after an ischemic stroke in patients with atrialfibrillation arises from the lack of extensive data on this matter. 51.66% of participants were women.
Stroke, Volume 55, Issue Suppl_1 , Page ATP223-ATP223, February 1, 2024. Background:A considerable portion of patients with embolic stroke of unknown source(ESUS)are later found to have occult atrialfibrillation (AF).
June 7, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of arrhythmia medicine pioneer Stuart J. His research impacted millions globally in the field of atrialfibrillation, stroke prevention and anticoagulation. Connolly, MD, on June 2.
milla1cf Mon, 01/08/2024 - 14:35 January 8, 2024 — University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center in the world to implant Medtronic’s Penditure Left Atrial Appendage (LAA) Exclusion System through a minimally invasive approach during a mitral valve repair procedure.
Circulation, Volume 150, Issue Suppl_1 , Page A4147213-A4147213, November 12, 2024. Introduction:Stroke prevention with anticoagulation is an important aspect of atrialfibrillation (AF) management. Anticoagulation is often based on the premise that the risk of stroke increases with each additional CHA2DS2VASc risk factor.
In an earlier post on Embolic Stroke of Undetermined Source (ESUS) , I had mentioned about ARCADIA trial (AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke) which was testing whether there is role for apixaban compared to aspirin for prevention of recurrent stroke in ESUS. 2023.27188.
Stroke, Volume 55, Issue Suppl_1 , Page AWP242-AWP242, February 1, 2024. Background & Aims:Some poly unsaturated fatty acids (PUFA) are said to be associated with the development of atrialfibrillation (AF). ω3/ω6 PUFA may have contrasting effects on the incidence of AF in acute ischemic stroke.
Stroke, Volume 56, Issue Suppl_1 , Page ATP13-ATP13, February 1, 2025. Background:Atrial fibrillation (AF) patients carry a high risk of stroke, and treatment related bleeding complications. 0.91), P<0.01), stroke by 19% (OR, 0.81(95%CI: 0.97), P=0.02), and hemorrhagic stroke by 57% (OR, 0.43(95%CI:
Circulation, Volume 150, Issue Suppl_1 , Page A4139226-A4139226, November 12, 2024. Background:Anticoagulation is the standard treatment for the majority of patients with atrialfibrillation (AF) to reduce the risk of stroke. Such patients are at high risk for bleeding and stroke.
Circulation, Volume 150, Issue Suppl_1 , Page A4137989-A4137989, November 12, 2024. Background:A bimodal P wave in lead II reflects left atrial remodeling and is described as a notched P wave. A notched P wave is also known to predict atrialfibrillation (AF) after catheter ablation. 5.83, P=0.001). 12.29, P=0.024).Conclusions:A
Publication date: Available online 26 September 2024 Source: The American Journal of Cardiology Author(s): Eduard Ródenas-Alesina, Jordi Lozano-Torres, Pablo Eduardo Tobías-Castillo, Clara Badia-Molins, Maria Calvo-Barceló, Rosa Vila-Olives, Guillem Casas-Masnou, Aleix Olivella San Emeterio, Toni Soriano-Colomé, Rubén Fernández-Galera, Ana B Méndez-Fernández, (..)
Dear Sirs, In the recent article ‘Drug therapies for stroke prevention’, under the heading entitled ‘Control of blood pressure’, the authors specified that “A systolic blood pressure (SBP) target of 120–129 mmHg should be routinely aimed for in those <65 years old….”.
Stroke, Volume 55, Issue Suppl_1 , Page AWP144-AWP144, February 1, 2024. Background:Large randomized clinical trials have established the superiority of Direct oral anticoagulants (DOACs) over Vitamin-K antagonists in atrialfibrillation (AF) related to Acute Ischemic stroke (AIS).
Stroke, Volume 55, Issue Suppl_1 , Page A66-A66, February 1, 2024. Introduction:Clinical practice guidelines recommend initiation of anticoagulation within 2 weeks after stroke due to atrialfibrillation (AF). Patients were randomized into one of 4 Arms: Day 3-4 from stroke onset, Day 6, Day 10, or Day 14.
The baseline CHA2DS2-VASc score helped to identify patient with subclinical atrialfibrillation (SCAF) in whom the benefit for reducing the risk of stroke and systemic embolism (SE) with an oral anticoagulant (OAC) was greater than the risk of increased major bleeding, according to a subgroup analysis from the ARTESiA study presented at Heart Rhythm (..)
Edoxaban was comparable to warfarin in preventing stroke or systemic embolism and intracardiac thrombus in patients with non-valvular atrialfibrillation (AFib) within three months after bioprosthetic valve surgery, based on preliminary findings from the ENBALV trial presented at AHA 2024.
Stroke, Volume 56, Issue Suppl_1 , Page AWP282-AWP282, February 1, 2025. Background:Atrial fibrillation is a common arrhythmia that increases the risk of stroke. Pooled analysis of primary and secondary endpoints showed that apixaban significantly reduced the risk of stroke or systemic embolism by 47% (OR, 0.53(95%CI:
Stroke, Volume 55, Issue Suppl_1 , Page AWP11-AWP11, February 1, 2024. Introduction:Patients with acute ischemic stroke (AIS) often present with conditions that require emergent anticoagulation (AC) other than atrialfibrillation (AF).
Stroke, Volume 55, Issue Suppl_1 , Page A138-A138, February 1, 2024. Introduction:Identification of atrialfibrillation (AF) in patients with stroke is critical for secondary stroke prevention with guideline-recommended oral anticoagulation (OAC). quality-adjusted life years (QALYs) versus SoC (6.63
milla1cf Thu, 04/04/2024 - 12:14 April 4, 2024 — Osso VR , a leader in immersive procedural training, announces the release of a co-developed curriculum with the American College of Cardiology ( ACC ). This collaboration expands Osso VR’s presence in the cardiovascular sector.
Circulation, Volume 150, Issue Suppl_1 , Page A4135095-A4135095, November 12, 2024. Background:While anticoagulation is crucial for atrialfibrillation (AF) patients to prevent ischemic events, those with thrombocytopenia have a potential increased risk of bleeding. 2.77, p < 0.001). 3.37, p < 0.001).
ABSTRACT Background Anemia is frequently observed as a comorbidity in atrialfibrillation (AF), especially in elderly patients and in those on anticoagulation. Methods We comprehensively searched PubMed, WOS, SCOPUS, EMBASE, and CENTRAL through March 2024 and conducted a prognostic systematic review and meta-analysis.
Circulation, Volume 150, Issue Suppl_1 , Page A4142210-A4142210, November 12, 2024. The importance of transesophageal echocardiogram (TEE) to exclude left atrial (LA) and left atrial appendage (LAA) thrombus prior to cardioversion for atrialfibrillation (AF) has been debated in patients who are anticoagulated prior to cardioversion.
Stroke: Vascular and Interventional Neurology, Volume 4, Issue 6 , November 1, 2024. BackgroundAtrial fibrillation (AF) is a known risk factor of ischemic stroke, and AFrelated stroke is twice more likely to be fatal. The average time to inpatient ICM implant was 4.1 days, with 77% in 5 days and 95.5%
Stroke: Vascular and Interventional Neurology, Volume 4, Issue 6 , November 1, 2024. Data on patients with acute ischemic stroke from the Third China National Stroke Registry were analyzed. Patients with preexisting heart diseases had higherprevalence of moderate or severe stroke at admission (4.7%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content